Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 3.87
(0.0%)
CNY 3.87
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.34 Billion CNY | 6.59% |
| 2022 | 6.89 Billion CNY | 6.24% |
| 2021 | 6.48 Billion CNY | -7.73% |
| 2020 | 7.03 Billion CNY | -0.23% |
| 2019 | 7.04 Billion CNY | 17.95% |
| 2018 | 5.97 Billion CNY | 23.92% |
| 2017 | 4.82 Billion CNY | 13.85% |
| 2016 | 4.23 Billion CNY | 10.27% |
| 2015 | 3.84 Billion CNY | 7.75% |
| 2014 | 3.56 Billion CNY | 2.47% |
| 2013 | 3.47 Billion CNY | 7.38% |
| 2012 | 3.24 Billion CNY | 7.33% |
| 2011 | 3.01 Billion CNY | 7.83% |
| 2010 | 2.79 Billion CNY | 241.44% |
| 2009 | 819.9 Million CNY | 40.52% |
| 2008 | 583.47 Million CNY | 17.03% |
| 2007 | 498.55 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 7.15 Billion CNY | -4.46% |
| 2024 Q1 | 7.79 Billion CNY | 6.05% |
| 2024 Q2 | 7.48 Billion CNY | -3.93% |
| 2023 Q2 | 7.18 Billion CNY | 1.42% |
| 2023 Q3 | 7.15 Billion CNY | -0.4% |
| 2023 FY | 7.34 Billion CNY | 6.59% |
| 2023 Q4 | 7.34 Billion CNY | 2.67% |
| 2023 Q1 | 7.08 Billion CNY | 2.78% |
| 2022 Q2 | 6.55 Billion CNY | 1.95% |
| 2022 Q1 | 6.43 Billion CNY | -0.84% |
| 2022 FY | 6.89 Billion CNY | 6.24% |
| 2022 Q4 | 6.89 Billion CNY | 3.67% |
| 2022 Q3 | 6.65 Billion CNY | 1.37% |
| 2021 Q3 | 6.58 Billion CNY | 0.14% |
| 2021 Q2 | 6.57 Billion CNY | -0.24% |
| 2021 Q1 | 6.59 Billion CNY | -6.29% |
| 2021 Q4 | 6.48 Billion CNY | -1.44% |
| 2021 FY | 6.48 Billion CNY | -7.73% |
| 2020 Q2 | 6.75 Billion CNY | -6.6% |
| 2020 Q4 | 7.03 Billion CNY | -1.05% |
| 2020 Q1 | 7.23 Billion CNY | 2.66% |
| 2020 FY | 7.03 Billion CNY | -0.23% |
| 2020 Q3 | 7.1 Billion CNY | 5.17% |
| 2019 Q2 | 6.73 Billion CNY | 1.34% |
| 2019 FY | 7.04 Billion CNY | 17.95% |
| 2019 Q4 | 7.04 Billion CNY | 2.71% |
| 2019 Q3 | 6.86 Billion CNY | 1.87% |
| 2019 Q1 | 6.64 Billion CNY | 11.23% |
| 2018 Q4 | 5.97 Billion CNY | 14.47% |
| 2018 Q1 | 4.92 Billion CNY | 2.03% |
| 2018 FY | 5.97 Billion CNY | 23.92% |
| 2018 Q2 | 4.99 Billion CNY | 1.46% |
| 2018 Q3 | 5.22 Billion CNY | 4.57% |
| 2017 Q1 | 4.34 Billion CNY | 2.61% |
| 2017 FY | 4.82 Billion CNY | 13.85% |
| 2017 Q4 | 4.82 Billion CNY | 7.98% |
| 2017 Q3 | 4.46 Billion CNY | 1.59% |
| 2017 Q2 | 4.39 Billion CNY | 1.15% |
| 2016 FY | 4.23 Billion CNY | 10.27% |
| 2016 Q4 | 4.23 Billion CNY | 6.5% |
| 2016 Q3 | 3.97 Billion CNY | 2.4% |
| 2016 Q1 | 3.89 Billion CNY | 1.49% |
| 2016 Q2 | 3.88 Billion CNY | -0.37% |
| 2015 Q3 | 3.55 Billion CNY | 0.79% |
| 2015 Q1 | 3.55 Billion CNY | -0.34% |
| 2015 Q4 | 3.84 Billion CNY | 7.98% |
| 2015 FY | 3.84 Billion CNY | 7.75% |
| 2015 Q2 | 3.52 Billion CNY | -0.66% |
| 2014 FY | 3.56 Billion CNY | 2.47% |
| 2014 Q3 | 3.35 Billion CNY | -1.36% |
| 2014 Q1 | 3.34 Billion CNY | -3.79% |
| 2014 Q4 | 3.56 Billion CNY | 6.41% |
| 2014 Q2 | 3.39 Billion CNY | 1.48% |
| 2013 Q4 | 3.47 Billion CNY | 9.08% |
| 2013 Q3 | 3.18 Billion CNY | 0.54% |
| 2013 Q2 | 3.17 Billion CNY | -1.99% |
| 2013 FY | 3.47 Billion CNY | 7.38% |
| 2013 Q1 | 3.23 Billion CNY | -0.1% |
| 2012 Q2 | 3.08 Billion CNY | 0.03% |
| 2012 FY | 3.24 Billion CNY | 7.33% |
| 2012 Q4 | 3.24 Billion CNY | 3.57% |
| 2012 Q3 | 3.12 Billion CNY | 1.39% |
| 2012 Q1 | 3.08 Billion CNY | 2.18% |
| 2011 Q4 | 3.01 Billion CNY | 7.25% |
| 2011 Q3 | 2.81 Billion CNY | -5.82% |
| 2011 Q2 | 2.98 Billion CNY | 1.96% |
| 2011 Q1 | 2.93 Billion CNY | 4.7% |
| 2011 FY | 3.01 Billion CNY | 7.83% |
| 2010 Q3 | 2.44 Billion CNY | 3.85% |
| 2010 Q1 | 932.9 Million CNY | 13.78% |
| 2010 Q2 | 2.35 Billion CNY | 152.68% |
| 2010 FY | 2.79 Billion CNY | 241.44% |
| 2010 Q4 | 2.79 Billion CNY | 14.35% |
| 2009 FY | 819.9 Million CNY | 40.52% |
| 2009 Q4 | 819.9 Million CNY | 0.0% |
| 2008 FY | 583.47 Million CNY | 17.03% |
| 2007 FY | 498.55 Million CNY | 0.0% |